Shandong Weigao Group Medical Polymer Company Limited (HKG:1066)
5.70
-0.07 (-1.21%)
Jun 6, 2025, 3:45 PM HKT
HKG:1066 Revenue
In the year 2024, Shandong Weigao Group Medical Polymer Company had annual revenue of 13.09B CNY, down -1.08%. Shandong Weigao Group Medical Polymer Company had revenue of 6.45B in the half year ending December 31, 2024, a decrease of -3.26%.
Revenue
13.09B CNY
Revenue Growth
-1.08%
P/S Ratio
1.89
Revenue / Employee
1.03M CNY
Employees
12,719
Market Cap
26.33B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 13.09B | -142.38M | -1.08% |
Dec 31, 2023 | 13.23B | -518.02M | -3.77% |
Dec 31, 2022 | 13.75B | 538.53M | 4.08% |
Dec 31, 2021 | 13.21B | 1.59B | 13.65% |
Dec 31, 2020 | 11.62B | 1.24B | 11.93% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BeOne Medicines | 32.53B |
Hansoh Pharmaceutical Group Company | 13.05B |
JD Health International | 61.89B |
Innovent Biologics | 10.03B |
WuXi Biologics | 19.87B |
CSPC Pharmaceutical Group | 28.99B |
Sino Biopharmaceutical | 30.72B |
Sichuan Kelun-Biotech Biopharmaceutical | 2.06B |